CDTX Cidara Therapeutics, Inc.

XNAS 221.40 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

CDTX $221.40 —
Key stats
$221.40
52-Week Range
$93.00 – $221.42
YTD
+0.17%
IV Rank (30D)
4.4
Straddle Price
$1.70
P/C Vol Ratio
0.08
Market Cap
$7.0B
Open
$221.32
Day Range
$221.25 – $221.41
Volume
2,691,011
Prev Close
$221.32
About
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS
Market Cap
$7.0B
Employees
73
List Date
2015-04-15
CIK
0001610618
Headquarters
San Diego, CA
Homepage
https://www.cidara.com

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 4196 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $220.58
SMA 50: $185.09
SMA 200: $83.68
Current: $221.38
EMA 12: $220.54
EMA 26: $212.51
MACD: 8.0256 | Signal: -2.9327
BULLISH
ADX (14): 73.39
STRONG TREND
+DI: 53.69
−DI: 8.55

Momentum Oscillators

RSI (14): 84.21
OVERBOUGHT
Stoch %K: 95.29
Stoch %D: 92.49
Williams %R: -2.65

Volume & Volatility

BB Upper: $221.47
BB Lower: $219.69
NEUTRAL
OBV: 73,352,740
Vol SMA 20: 1,046,711
Vol ROC: 42.98%
ATR: $1.62
True Range: $0.16
HV 20: 2.4%
HV 30: 2.9%
HV 60: 152.0%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-01-09T00:00:00 – 2026-01-06T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 8/10)

Key drivers: Acquisition bid from Merck, positive news sentiment, technical momentum

Primary risks: Overbought RSI, potential pullback to Bollinger Bands

Investment thesis: CDTX is likely to continue its upward trend driven by the acquisition bid and positive market sentiment. However, there are signs of overbuying and a potential pullback to the Bollinger Bands, making it essential to monitor risk levels.

Recent news sentiment impact: The news headlines have been overwhelmingly positive, contributing to the stock's surge.

Generated
Earnings History
7 of 8 under expected move
Avg Expected Move
94.47%
Avg Actual Move
4.63%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2023-03-02 After-Close 2.21% 14.09% 6.38x Exceeded
2023-05-11 After-Close 110.57% 0.85% 0.01x Within
2023-08-03 After-Close 135.19% 4.29% 0.03x Within
2024-08-13 After-Close 206.12% 5.84% 0.03x Within
2024-11-07 After-Close 247.06% 2.97% 0.01x Within
2025-05-08 After-Close 28.72% 2.72% 0.09x Within
2025-08-07 After-Close 11.22% 0.44% 0.04x Within
2025-11-06 After-Close 14.70% 5.83% 0.40x Within

Earnings calendar: this week’s reports with expected vs actual moves →

CDTX Options Activity & IV Rank

CDTX IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 8.7%
7-DTE IV: 9.8%
Expected Move: $1.70
7-DTE Move: $1.68
Days to Exp: 45 (2026-02-20)

Options Flow

Call Volume: 2,167
Put Volume: 175
P/C Volume: 0.081
BULLISH
Call OI: 5,496
Put OI: 5,436
P/C OI: 0.989
Total OI: 10,932

ATM Options Pricing

ATM Call: $1.57
ATM Put: $0.12
Call %: 0.7%
Put %: 0.1%

Chain Summary

Chain Volume: 5,847
Chain OI: 41,110
Last Updated: 1/6/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 78th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
78%
vs own history
GEX tilt
+0.53
OI-weighted, today
Vanna tilt
+0.78
δ-sensitivity to IV
Charm tilt
-0.91
δ-decay vs time
Vanna tilt +0.78: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.91: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 41 ATM contracts, 30k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Jan 6 · No data
30 DTE / 10d —
— pts EXTREME
as of Jan 6 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)1.7LowJan 6
IV Rank (30 DTE)4.4LowJan 6
Straddle Price (30 DTE)$1.70Jan 6
Beta Analysis
Insufficient price history — listed 4196 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.

CDTX Institutional Ownership (13F)

Latest filings — 2025-12-31
Diluted shares outstanding: 15,739,285 (as of 2025-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

8 filers2,574,427 shares$560.52M value16.36% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 2,007,193 $443.37M 79.10% 12.75% 2025-12-31
2 OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 315,474 $69.69M 12.43% 2.00% 2025-12-31
3 KRYGER CAPITAL Ltd 185,313 $40.93M 7.30% 1.18% 2025-12-31
4 AXA Investment Managers S.A. 61,154 $5.86M 1.04% 0.39% 2025-09-30
5 Bryce Point Capital, LLC 3,977 $380.84K 0.07% 0.03% 2025-09-30
6 CIBC WORLD MARKETS CORP 1,297 $286.49K 0.05% <0.01% 2025-12-31
7 COMERICA BANK Custodian 12 $2.56K <0.01% <0.01% 2025-12-31
8 CIBC Private Wealth Group LLC 7 $1.55K <0.01% 0.00% 2025-12-31
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

CDTX Insider Trading (Form 4)

Latest: 2026-01-07
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-01-07 James Merson Director Disp (D) −17,475 opt — EDGAR
2026-01-07 Ryan Spencer Director Disp (D) −17,475 opt — EDGAR
2026-01-07 Joshua Resnick Director Disp (D) −27,279 opt — EDGAR
2026-01-07 Shane Ward COO & CLO Disp (D) −25,083 $221.50 -$5.56M EDGAR
2026-01-07 Bonnie L Bassler Director Disp (D) −15 $221.50 -$3.3K EDGAR
2026-01-07 Frank Karbe Chief Financial Officer Disp (D) −50,651 $221.50 -$1.67M EDGAR
2026-01-07 Jeffrey Stein President & CEO Disp (D) −75,640 $221.50 -$16.75M EDGAR
2026-01-07 Carin Canale-Theakston Director Disp (D) −35,375 opt — EDGAR
2026-01-07 Chrysa Mineo Director Disp (D) −3,320 $221.50 -$735.4K EDGAR
2026-01-07 Theodore R Schroeder Director Disp (D) −41,100 opt — EDGAR
2026-01-07 Jeffrey Stein President & CEO Mixed −1,864 $79.55 — EDGAR
2026-01-07 Daniel D Burgess Director Disp (D) −150 $221.50 -$33.2K EDGAR
2026-01-07 Nicole Negar Davarpanah Chief Medical Officer Disp (D) −20,886 $221.50 -$2.78M EDGAR
2025-12-29 Nicole Negar Davarpanah Chief Medical Officer Gift (G) −450 — EDGAR
2025-12-29 Jeffrey Stein President & CEO Gift (G) −5,425 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

CDTX Insider Holdings

6 insiders · @ $221.38
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Rajeev M. Shah Director 3,365,523 $745.06M $400.00M 2 2025-06-30
2 RA Capital Healthcare Fund LP Director 1,092,796 $241.92M $0 3 2025-01-07
3 Frank Karbe Chief Financial Officer 43,125 $9.55M $0 3 2026-01-07
4 Leslie Tari CHIEF SCIENTIFIC OFFICER 16,288 $3.61M -$111.2K 15 2025-03-13
5 Jeffrey Stein President & CEO 10,072 $2.23M $2.31M 36 2026-01-07
6 Nicole Negar Davarpanah Chief Medical Officer 8,333 $1.84M -$29.8K 5 2026-01-07
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
5 ETFs hold CDTX
5 shown · $2.69M total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 USVM VictoryShares US Small Mid Cap Value Momentum ETF Nport 0.18% $2.1M — 2026-06-30
2 FESM Fidelity Enhanced Small Cap ETF Nport 0.01% $486,179 — 2026-06-30
3 NXTI Simplify Next Intangible Core Index ETF Nport 0.14% $48,596 — 2026-06-30
4 PINK Simplify Health Care ETF Nport 0.01% $34,901 — 2026-06-30
5 SHRT Gotham Short Strategies ETF Nport 0.03% $3,976 — 2026-09-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-10.63
TTM Revenue
$0.00
TTM Net Income
$-184.74M
TTM Op. Cash Flow
$-132.94M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '252025-09-30—$-83.23M$-3.10$-40.62M
Q2 '252025-06-30—$-25.72M$-1.65$-40.96M
Q1 '252025-03-31—$-23.48M$-1.66$-21.95M
Q4 '242024-12-31$0.00$-52.31M$-4.22$-29.41M
Q3 '242024-09-30—$-15.98M$-2.45$-36.70M
Q2 '242024-06-30$302.00K$-91.21M$-19.99$-103.78M
Q1 '242024-03-31$973.00K$-10.33M$-2.28$-6.64M
Q4 '232023-12-31$2.76M$-3.21M$-0.69$-12.72M
Q3 '232023-09-30$9.22M$-9.11M$-2.02$-1.63M
Q2 '232023-06-30$5.09M$-13.62M$-3.02$2.82M
Q1 '232023-03-31$26.11M$2.38M$0.60$-10.90M
Q4 '222022-12-31$10.38M$-17.16M$-4.80$-21.00M
Q3 2025 • period ending 2025-09-30 • filed 2025-11-06
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
—
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-43.7%
ROA
-35.6%
Div Yield
—
FCF Yield
—
Debt/Equity
0.00
Current Ratio
—
Market Cap
$0.00
as of 2026-01-07
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
1.88M
SI % of Float
8.77%
Days to Cover
2.23
Short Vol Ratio
32.4%
Free Float
21.46M
Float %
68.3%
Short interest 2025-12-31 • Short volume 2026-01-06 • Float 2025-11-17